Clinical trial
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
NCT00295308 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00295308 |
|---|---|
| Title | Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients |
| Official title | Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Clonidine, Placebo |
| Enrollment | 208 |
| Start date | Nov 8, 2005 |
| Completion | Jul 30, 2014 |
| First posted | Feb 23, 2006 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: